Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what falsifiable science actually supports before you trust the answer.

Press Enter ↡ to search evidence


     Quick Explanation



    This 2009 review by Borradaile & Pickering is a well-sourced early synthesis arguing that SIRT1-7 act on the cardiovascular system both directly (eNOS, p53, AT1R) and indirectly via whole-body metabolism, and that NAD+ availability (via Nampt/NMN) is a co-limiting therapeutic lever . It anticipated the NMN/NAD+-boosting field, but its translational claims rest on mouse and cell data that later work complicated.


     Long Explanation



    Scope and thesis

    This narrative review consolidates evidence that SIRT1-4 improve metabolic control in adipose, liver, muscle, and pancreas (indirect cardiovascular benefit), while SIRT1 and SIRT7 act directly on heart and vessel wall: SIRT1 deacetylates eNOS (Lys496/506), FoxO1, and p53, and represses AT1R; SIRT7-deficient mice develop hypertrophy and inflammatory cardiomyopathy via p53 hyperacetylation . The authors' distinctive contribution is framing sirtuin activity as NAD+-supply-limited: PARP1 activation during heart failure depletes NAD+, and Nampt/Nmnat overexpression preserves SIRT1 activity and cell survival .

    Quantitative support for direct sirtuin activation by resveratrol later emerged but is substrate-specific and modest: at 0.2 mM resveratrol activates Sirt5 ~2.5-fold on FdL1 yet inhibits Sirt3; piceatannol activates Sirt5 with EC50 0.076 Β± 0.02 mM . The paper itself flags the key controversy correctly, noting that polyphenol effects may reflect stress-response hormesis rather than direct activation, and that assay artifacts plague SIRT1 activator claims .

    What the field did with the prediction

    The review's Nampt/NAD+ thesis proved prescient: NAD+ biosynthesis is now framed as a circadian, inter-organ system (eNAMPT/NMN axis) relevant to cardiac and metabolic aging , and a recent preprint links a FNDC1-NAMPT-NAD axis to arterial disease and vascular calcification, extending the vascular-NAMPT connection the authors established in smooth muscle cells .

    Blindspots and what would change the verdict

    The review omits NAD+ consumer competition (PARP/CD38 as systemic NAD+ sinks) and circadian regulation, which later proved central . All cited in vivo data are mouse/rat/monkey; no human outcome trials existed, and downstream human resveratrol/NMN trials have underdelivered on cardiovascular endpoints β€” data showing strain-dependent SIRT1 knockout phenotypes (which the authors did acknowledge) was an early warning. Findings showing NMN/NR fail to extend lifespan beyond redox-perturbation effects would weaken the supply-limitation model . Confidence: moderate β€” strong mechanistic curation, weak translational evidence base.



    Feedback:    

    Updated: November 17, 2026

     BGPT Paper Review



    Study Novelty

    70%

    For 2009, explicitly linking NAD+ biosynthesis (Nampt/NMN) to cardiovascular sirtuin activity was forward-looking; the core sirtuin biology was already reviewed by Guarente, Verdin, and Auwerx.



    Scientific Quality

    70%

    Well-referenced, balanced (acknowledges strain-dependent knockouts and resveratrol controversy), but as a narrative review it inherits publication/positive-result bias of the primary mouse studies and contains no quantitative synthesis.



    Study Generality

    70%

    Integrates metabolism, myocardial biology, and vascular biology into a unifying NAD+-sirtuin framework, but mechanism-by-mechanism coverage is tissue-specific rather than generating generalizable principles.



    Study Usefulness

    70%

    Practically useful as a roadmap for NAD+-boosting and sirtuin-activator drug development in CVD; its predictions (Nampt, NMN) directly seeded later work, though no actionable clinical guidance.



    Study Reproducibility

    50%

    Review article synthesizing others' knockouts, overexpression, and pharmacology; reproducible only insofar as the underlying mouse/cell studies replicate, several of which later showed strain dependence.



    Explanatory Depth

    70%

    Strong mechanistic chain (p53/eNOS/FoxO1 deacetylation -> phenotype; PARP-NAD+ depletion -> SIRT1 loss), but stops short of quantitative flux or dose-response modeling of NAD+ limitation.

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Resveratrol as a direct, potent SIRT1 activator in vivo β€” undermined by substrate-specific, artifact-prone Fluor de Lys assays and failure to reproduce direct activation at physiological concentrations.


    'Sirtuins are universal longevity genes' β€” mammalian SIRT1 knockout lifespan effects are strain- and context-dependent, unlike yeast Sir2.

     Science Movie



    Make a narrated HD Science movie for this answer ($64 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT